Cell Biochemistry and Function · 1985 · 19 citations · 15 references
MedicineBiochemistryOncologyMolecular OncologyNeoplasiaTumor MicroenvironmentCell-matrix AdhesionCollagen DepositionExtracellular MatrixTumor Microenvironment InteractionsTumor-stroma InteractionsCell Adhesion To CollagenPorphyrin Accumulation
We have already reported in Balb C mouse transplantable mammary carcinoma, that uroporphyrin I and III are superior as tumour localizers when compared to hematoporphyrin derivative and a derivative thereof, photofrin II. This study compares the binding of porphyrins to proteins which may be found in tumour cells or stroma to investigate whether there is a common binding determinant. Coproporphyrin III and deuteroporphyrin IX which are non-tumour localizing porphyrins, were also part of the comparative study. The interaction of these porphyrins with acid soluble collagen and acid insoluble collagen, elastin, and fibrin was evaluated, and the binding of uroporphyrin isomers I and III and deuteroporphyrin IX to gelatin and fibrinogen, was also determined. The results suggest that collagen, especially the acid soluble form, and gelatin preferentially bind the four porphyrins which localize in mammary carcinoma tissue. The well reported observations that malignant epithelial cells, including breast cancer, produce collagen and contain a rate-limiting enzyme in collagen biosynthesis would support the notion that de novo synthesis of this protein may in part govern the tumour uptake and retention of porphyrins. Elastin, fibrinogen and fibrin showed non-discriminant binding to the porphyrins under study.
15
Porphyrin localization and treatment of tumors
E. J. Land · British Journal of Cancer · 1985 · 636 citations · Full text
Medicine, Oncology, Pharmacology +11
A murine tumor producing a matrix of basement membrane.
Roslyn W. Orkin, P Gehron, Ermona B. McGoodwin et al. · The Journal of Experimental Medicine · 1977 · 630 citations · Full text
Richard L. Lipson, Edward J. Baldes, Arthur M. Olsen · JNCI Journal of the National Cancer Institute · 1961 · 629 citations
Medicine, Hematology, Oncology +9